These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 21842704)
1. Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines. Romanò L; Zanetti AR J Prev Med Hyg; 2011 Jun; 52(2):45-6. PubMed ID: 21842704 [No Abstract] [Full Text] [Related]
2. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F; Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297 [TBL] [Abstract][Full Text] [Related]
3. Loss of antibodies, but not of protection. Wenzel JJ; Jilg W Lancet Infect Dis; 2010 Nov; 10(11):738-9. PubMed ID: 21029981 [No Abstract] [Full Text] [Related]
4. Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy. Behre U; Van Der Meeren O; Crasta P; Hanssens L; Mesaros N Hum Vaccin Immunother; 2016 Nov; 12(11):2916-2920. PubMed ID: 27653771 [TBL] [Abstract][Full Text] [Related]
5. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses. Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692 [TBL] [Abstract][Full Text] [Related]
6. Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine. Van Der Meeren O; Bleckmann G; Crasta PD Hum Vaccin Immunother; 2014; 10(6):1682-7. PubMed ID: 24637296 [TBL] [Abstract][Full Text] [Related]
7. Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy. Zanetti A; Parlato A; Romanò L; Desole MG; Ferrera G; Giurdanella F; Zuliani M; Richard P; Thomas S; Fiquet A Vaccine; 2012 Aug; 30(39):5770-5. PubMed ID: 22789511 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level. Carollo M; Palazzo R; Bianco M; Pandolfi E; Chionne P; Fedele G; Tozzi AE; Carsetti R; Romanò L; Ausiello CM Vaccine; 2013 Jan; 31(3):506-13. PubMed ID: 23174200 [TBL] [Abstract][Full Text] [Related]
9. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy. Zanetti A; Desole MG; Romanò L; d'Alessandro A; Conversano M; Ferrera G; Panico MG; Tomasi A; Zoppi G; Zuliani M; Thomas S; Soubeyrand B; Eymin C; Lockhart S Vaccine; 2017 Jul; 35(32):4034-4040. PubMed ID: 28624307 [TBL] [Abstract][Full Text] [Related]
10. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781 [TBL] [Abstract][Full Text] [Related]
11. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age. Halperin SA; Tapiero B; Diaz-Mitoma F; Law BJ; Hoffenbach A; Zappacosta PS; Radley D; McCarson BJ; Martin JC; Brackett LE; Boslego JW; Hesley TM; Bhuyan PK; Silber JL Vaccine; 2009 Apr; 27(19):2540-7. PubMed ID: 19124057 [TBL] [Abstract][Full Text] [Related]
13. Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example. Rosado MM; Scarsella M; Pandolfi E; Cascioli S; Giorda E; Chionne P; Madonne E; Gesualdo F; Romano M; Ausiello CM; Rapicetta M; Zanetti AR; Tozzi A; Carsetti R Eur J Immunol; 2011 Jun; 41(6):1800-8. PubMed ID: 21469123 [TBL] [Abstract][Full Text] [Related]
14. A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines. Giambi C; Bella A; Barale A; Montù D; Marchisio M; Oddone M; Zito S; Rapicetta M; Chionne P; Madonna E; Ciofi degli Atti ML BMC Infect Dis; 2008 Jul; 8():100. PubMed ID: 18662386 [TBL] [Abstract][Full Text] [Related]
15. Persistence of Hepatitis B Immune Memory Until 6 Years of Age Following Hexavalent DTaP-IPV-HB-PRP~T Vaccination in a 3-, 5- and 11- to 12-month Schedule and Response to a Subsequent Hepatitis B Challenge Vaccination. Virta M; Soininen A; Patel DM; Petit C; Tabar C; Lyabis O Pediatr Infect Dis J; 2021 Jan; 40(1):e28-e30. PubMed ID: 33284254 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L; Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171 [TBL] [Abstract][Full Text] [Related]
17. Review of a new fully liquid, hexavalent vaccine: Hexaxim. Nunes MC; Madhi SA Expert Opin Biol Ther; 2013 Apr; 13(4):575-93. PubMed ID: 23441818 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine. Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine. Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013 [TBL] [Abstract][Full Text] [Related]
20. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity. Ciarlet M; He S; Lai S; Petrecz M; Yuan G; Liu GF; Mikviman E; Heaton PM; Panzer F; Rose T; Koller DY; Van Damme P; Schödel F Pediatr Infect Dis J; 2009 Mar; 28(3):177-81. PubMed ID: 19209092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]